FOSUN HEALTH Logo

Polycystic Ovary Syndrome Diagnosis

catalogue

Polycystic Ovary Syndrome Diagnosis

Polycystic Ovary Syndrome Diagnosis

The diagnosis is a pattern, and the pattern is defined: two of three features, established from the cycle history, the androgen assessment and the ultrasound. Running alongside that is the second half of the assessment, which is exclusion — thyroid dysfunction, a raised prolactin, and in selected cases a rare adrenal cause all produce irregular cycles or androgen excess and all need different treatment. The metabolic picture is measured separately rather than inferred.

The diagnosis is a pattern rather than a test

No single result settles this, and the reason is that the condition is defined by a combination:

  • Two of three features are required, and any two will do. Infrequent or absent ovulation, evidence of androgen excess, and the ovarian appearance on ultrasound. This means there are several routes into the diagnosis and therefore several ways to meet it without ever having the scan appearance.
  • The features are established by different methods. Ovulation from the history, androgen excess from examination and a blood test, the ovarian appearance from imaging. No one method can substitute for another, which is why the assessment is assembled rather than ordered as a panel.
  • “Possible” and “confirmed” are different statements. Where only one feature is present, or where a result is borderline, the honest position is that the criteria are not yet met rather than that a diagnosis has been made or excluded. That position has a plan attached: complete the missing assessment.

Why a single abnormal result is not treated as the answer. A scan appearance without the other features, or a mildly raised androgen without a cycle change, describes something real but not this diagnosis. Acting on it as though it were leads to treatments given for a condition the woman does not have, and to the features she does have going unaddressed.

What counts for each of the three criteria

Each feature has a defined threshold, and the definitions are worth knowing because they are frequently applied loosely:

  • Ovulation that is infrequent or absent. Established from cycle intervals over a period of months. A cycle that is consistently long, or one that varies widely, or bleeding that has stopped for several months, all count. A single unusual cycle does not.
  • Evidence of androgen excess, clinical or biochemical. Clinical evidence is acne, hair growth in a male pattern and scalp thinning, judged by distribution. Biochemical evidence is a raised free androgen index, calculated from testosterone and sex hormone binding globulin, on a morning sample. Either route is sufficient.
  • The ovarian appearance on ultrasound. Many small follicles arranged along the periphery of the ovary, with the threshold for what counts defined by the protocol in use and by the resolution of the equipment. In adults it is read as present or absent rather than as a count, and the criteria are not applied to a scan performed with an older technique.

Why the thresholds are stated rather than left to impression. Applying the criteria loosely goes in both directions — diagnosing from a scan alone, and dismissing the condition because the scan was normal. Knowing what counts is what makes the diagnosis reproducible.

What the ultrasound does and does not establish

The scan is one of the three features, and it is the one most often over-read:

  • The technique and the criteria matter. The finding is defined by a protocol, including how the ovary is measured and what equipment was used. A report that states the appearance without stating the protocol is difficult to interpret confidently.
  • A normal scan does not exclude the diagnosis. Where ovulation is infrequent and androgen excess is present, the criteria are met regardless of the appearance. Treating a normal scan as an answer is how a diagnosis is missed.
  • The appearance alone does not make the diagnosis. It occurs in a substantial proportion of women with regular cycles and normal androgens, and in that situation it is recorded as a finding and nothing more.
  • The scan has other work to do as well. It examines the uterus and the lining, which is relevant both to the fertility question and to the protection of the lining where ovulation has been infrequent, and it is an opportunity to note anything else that turns up.

Why the scan is put in its place rather than taken away. It is a genuine criterion and it carries information, particularly about the uterus and the lining. What it is not is a diagnostic test on its own, and the difference between those two uses is the difference between a diagnosis that holds and one that has to be withdrawn.

The hormone tests, and the conditions that imitate the picture

Half of a competent assessment is exclusion, and the conditions excluded are common enough to be worth naming:

  • Thyroid function. Both an overactive and an underactive thyroid disturb the cycle, and both are treated in a way that has nothing to do with ovarian function. It is a first-line test rather than a refinement.
  • Prolactin. A raised level interrupts ovulation and can be caused by medication, by a benign pituitary finding, or by nothing that is found. It is treatable, and it does not respond to treatment for polycystic ovary syndrome.
  • Follicle-stimulating hormone, where the history suggests ovaries that have stopped rather than ovaries that are not ovulating. A high level with an irregular or absent cycle points towards primary ovarian insufficiency, which is a different condition with different implications.
  • A rare adrenal cause, where the androgen picture is marked. A morning 17-hydroxyprogesterone, and occasionally a short test, identifies a condition present from birth that produces a very similar androgen picture and is managed entirely differently.

Why exclusion comes before treatment. Each of these conditions produces part of the same picture and each is treated differently. A diagnosis settled without excluding them leads to treatment that does not work and to a plan that has to be restarted.

The metabolic assessment, which is not optional

This part is assessed in its own right rather than inferred from weight or from the diagnosis:

  • Glucose handling. A test of glucose tolerance establishes whether insulin resistance or a raised blood sugar is present, and it is the measurement that the rest of the metabolic plan is built on. Neither weight nor waist measurement substitutes for it.
  • Lipids, and blood pressure. Recorded because the long-term picture is a combination rather than a single number, and because they are what a review years later will be compared against.
  • Waist measurement rather than weight alone. Where fat is carried matters to the metabolic picture, and a waist measurement is a more useful baseline than a scale reading.
  • Why it is measured in everyone rather than where the picture suggests it. Insulin resistance is common in this condition and is frequently silent, and a woman of any weight may have it. Waiting for a sign means missing the part with the longest consequences.

Why this section sits in an assessment that a patient came to for irregular periods. The metabolic part of the condition is the part that continues after the fertility question has been answered. Establishing a baseline at the point of diagnosis is what makes later comparison meaningful, and it is easier to act on a documented result than on an impression.

What is not looked for, and why

A useful assessment is defined as much by what it leaves out as by what it includes:

  • Ovarian hormones repeated at intervals are not part of the diagnosis. The criteria are applied once, from the history, the androgen assessment and the ultrasound, and further measurements of the same hormones do not change the diagnosis.
  • An ovarian scan is not repeated for the diagnosis. Once the appearance has been recorded against a defined protocol it does not need to be re-established, and repeating it adds nothing to the diagnosis.
  • Androgen levels are not followed as a monitoring test. They are used to establish the feature, and treatment is judged by what the woman notices and by the results it is meant to produce rather than by re-measuring testosterone.

Why saying no is part of the plan. A woman who has had irregular periods for years will accept almost any test that is offered, and a test that cannot change what happens next still costs money, time and the impression that something has been found. The useful end point is a small number of answers with reasons attached.

Frequently Asked Questions

Do I need another scan if my first one was normal?

Not to establish the diagnosis. If the cycle history and the androgen assessment already meet two of the three criteria, the diagnosis holds and the absence of the scan appearance changes nothing. Where the scan was performed with an older technique, or where the result is unclear, a scan performed to a defined protocol can add information — particularly about the uterus and the lining. What a repeat scan is not is a way of confirming or excluding the diagnosis that the other two features have already settled.

What should my testosterone result be to count?

What matters is the free androgen index rather than the total testosterone on its own, which is why sex hormone binding globulin is measured at the same time. A total level that looks normal can correspond to a raised free fraction, and the reverse also occurs. The sample is best taken in the morning, because levels vary through the day. And a biochemical result is only one of the two routes to the feature: clear clinical signs on examination establish androgen excess whether or not the blood test is abnormal.

Why are thyroid and prolactin tested when the diagnosis seems obvious?

Because both produce the same kind of cycle disturbance and both are treated differently. An underactive or overactive thyroid interrupts ovulation, and a raised prolactin does the same; treating either as polycystic ovary syndrome means treating a condition the woman does not have while her actual problem continues. The tests are inexpensive, they are done once, and they are the difference between a diagnosis that holds and one that has to be revised.

Is there a test that shows insulin resistance directly?

Glucose handling is what is measured, through a test of glucose tolerance, and it is the result the metabolic plan is built on. Fasting glucose alone can miss the picture, and neither weight nor waist measurement is a substitute. Where the result is abnormal, or where it sits at the boundary, it becomes a measurement worth repeating at defined intervals rather than a single test taken once and filed — which is the practical reason for establishing it at the point of diagnosis.

Patient Stories

Stories from our polycystic ovary syndrome programme, pulled automatically from the patient story library by disease tag.

View all patient stories →

Send the scan report, the blood results, and how long the cycles have been irregular.

The cycle history with its range, any ultrasound of the ovaries with the date and the technique used, thyroid and prolactin results if they exist, androgen results with the time of day the sample was taken, and the medication list. What comes back is a written view of which criteria are met and what still needs to be excluded.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*